查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1559694

良性摄护腺增生治疗设备的全球市场

Benign Prostatic Hyperplasia Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球良性前列腺增生治疗设备市场预计将达到8.165亿美元

良性摄护腺增生治疗设备的全球市场预计 2023 年为 5.828 亿美元，预计到 2030 年将达到 8.165 亿美元，2023-2030 年分析期间复合年增长率为 4.9%。医院最终用途是本报告分析的细分市场之一，预计复合年增长率为 5.3%，到分析期结束时将达到 4.969 亿美元。在分析期间，泌尿系统诊所最终用途细分市场的复合年增长率预计为 4.4%。

美国市场预估为1.585亿美元，中国预期复合年增长率为4.7%

预计2023年美国良性前列腺增生治疗设备市场规模将达1.585亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到1.295亿美元，2023-2030年分析期间复合年增长率为4.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.7% 和 4.1%。在欧洲，德国的复合年增长率预计为 4.9%。

全球良性前列腺增生治疗设备市场—主要趋势与驱动因素总结

前列腺增生治疗仪在现代治疗中扮演什么角色？

良性摄护腺增生 (BPH) 治疗设备是治疗良性摄护腺增生的重要工具，提供微创解决方案，可显着减少与此情况相关的症状和併发症，这种情况在老年男性中很常见。这些设备是传统手术方法的替代方案，可以实现更有针对性、对患者友善的治疗。 BPH治疗设备包括多种技术，包括经尿道前列腺切除术（TURP）设备、雷射治疗系统、前列腺支架以及蒸汽疗法和前列腺尿道提升（PUL）系统等新治疗方法。透过移除或重新定位阻塞尿道的多余前列腺组织，这些装置可以改善尿流并缓解相关症状，例如频尿和闭尿症。这些先进设备的引入扩大了男性的选择范围，从而可以根据其特定的健康需求和恢復目标制定更个人化的治疗策略。

技术创新如何提高 BPH 治疗设备的有效性？

技术创新显着提高了 BPH 治疗设备的疗效和安全性，从而改善了患者预后并提供了更广泛的治疗选择。钬雷射前列腺切割术(HoLEP) 等雷射治疗系统利用精密雷射技术以微创方式去除多余的组织，从而降低与传统手术方法相关的风险。蒸汽疗法等创新治疗方法利用水蒸气收缩前列腺组织，是非侵入性的，可提供良好的长期效果。此外，前列腺尿道提升 (PUL) 系统的发展彻底改变了 BPH 治疗，提供了一种无需切割或切除前列腺组织即可物理重新定位的方法，从而保留性功能并保证更快的恢復。这些进步不仅提高了 BPH 治疗的成功率，而且还使其更容易获得且对患者生活的干扰更少，从而鼓励更多的男性寻求此类创新解决方案。

为什么整个医疗保健系统对 BPH 治疗设备的需求不断增加？

由于几个重要趋势，整个医疗保健系统对 BPH 治疗设备的需求正在迅速增加。由于全球老年人口的不断增长，前列腺增生症的盛行率不断增加，这增加了对有效和微创治疗方案的需求。 BPH 治疗设备特别有吸引力，因为当今的患者资讯更加丰富，通常更喜欢恢復时间更短、风险更低的门诊手术。人们对 BPH 症状的认识不断提高，以及先进治疗方案的出现，促使更多男性儘早医，并增加了对 BPH 治疗设备的需求。此外，转向以价值为基础的医疗保健模式，重点是改善患者的治疗效果，同时降低成本，这促使医疗保健提供者采用可以提供高品质、高效护理的 BPH 治疗设备，这是我正在推动的。这些因素导致 BPH 设备的使用增加，这些设备正在成为现代泌尿系统医学的一个组成部分。

推动BPH设备市场成长的关键因素是什么？

BPH 治疗设备市场的成长受到多种因素的推动，包括老龄化人口中 BPH 盛行率的增加以及需要治疗的患者人数的增加。医疗技术的发展，特别是雷射治疗和前列腺尿道提升系统等微创手术的发展，也透过提供更安全、更有效的治疗选择来推动市场成长。人们越来越偏好门诊治疗，这可以减少住院时间和医疗费用，进一步推动了这些设备的采用。此外，人们对 BPH 及其对生活品质影响的认识不断提高，导致更多男性寻求早期疗育，从而增加了对创新 BPH 治疗设备的需求。随着这些趋势的持续发展，在持续的技术创新和对有效且患者友好的治疗解决方案日益增长的需求的支持下，良性前列腺增生设备市场预计将出现强劲增长。

受访企业范例（38家知名企业）

  • Biolitec, Inc.
  • Boston Scientific Corporation
  • Lumenis Be Ltd.
  • Olympus Corporation
  • UK MEDS DIRECT Limited
  • Urologix, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP10675

Global Benign Prostatic Hyperplasia Devices Market to Reach US$816.5 Million by 2030

The global market for Benign Prostatic Hyperplasia Devices estimated at US$582.8 Million in the year 2023, is expected to reach US$816.5 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$496.9 Million by the end of the analysis period. Growth in the Urology Clinics End-Use segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$158.5 Million While China is Forecast to Grow at 4.7% CAGR

The Benign Prostatic Hyperplasia Devices market in the U.S. is estimated at US$158.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$129.5 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Benign Prostatic Hyperplasia Devices Market - Key Trends and Drivers Summarized

What Role Do Benign Prostatic Hyperplasia Devices Play in Modern Treatment?

Benign Prostatic Hyperplasia (BPH) devices are essential tools in the management of prostate enlargement, offering minimally invasive solutions that significantly reduce the symptoms and complications associated with this common condition in aging men. These devices provide alternatives to traditional surgical approaches, enabling more targeted and patient-friendly treatments. BPH devices include a range of technologies such as transurethral resection of the prostate (TURP) instruments, laser therapy systems, prostatic stents, and newer treatments like water vapor therapy and prostatic urethral lift (PUL) systems. By either removing or repositioning excess prostate tissue that blocks the urethra, these devices improve urinary flow and alleviate related symptoms like frequent urination and urinary retention. The introduction of these advanced devices has expanded the options available to men, allowing for more personalized treatment strategies that align with their specific health needs and recovery goals.

How Are Technological Innovations Enhancing BPH Device Effectiveness?

Technological innovations have significantly enhanced the effectiveness and safety of BPH devices, leading to better patient outcomes and broader treatment options. Laser therapy systems, such as holmium laser enucleation of the prostate (HoLEP), leverage precision laser technology to remove excess tissue with minimal invasiveness, reducing the risks associated with traditional surgical methods. Innovations like water vapor therapy, which utilizes steam to shrink prostate tissue, offer a non-invasive alternative with excellent long-term results. Additionally, the development of prostatic urethral lift (PUL) systems has revolutionized BPH treatment by providing a method to physically reposition the prostate tissue without cutting or removing it, thus preserving sexual function and ensuring quicker recovery. These advancements are not only improving the success rates of BPH treatments but also making them more accessible and less disruptive to patients' lives, encouraging more men to seek out these innovative solutions.

Why Is There Increasing Demand for BPH Devices Across Healthcare Systems?

The demand for BPH devices is rapidly increasing across healthcare systems due to several key trends. The growing elderly population worldwide is leading to a higher incidence of BPH, creating a greater need for effective, minimally invasive treatment options. Patients today are more informed and often prefer outpatient procedures that offer shorter recovery times and lower risks, which makes BPH devices particularly appealing. Increased awareness about BPH symptoms and the availability of advanced treatment options are prompting more men to seek medical attention earlier, thereby boosting the demand for these devices. Additionally, the shift towards value-based healthcare models, which focus on improving patient outcomes while reducing costs, is driving healthcare providers to adopt BPH devices that can deliver high-quality, efficient care. These factors are contributing to the growing utilization of BPH devices, which are becoming an integral part of modern urological care.

What Are the Key Factors Driving the Growth of the BPH Devices Market?

The growth in the BPH devices market is driven by several factors, including the rising prevalence of BPH among the aging population, which is expanding the pool of patients requiring treatment. Advances in medical technology, particularly in the development of less invasive procedures such as laser therapies and prostatic urethral lift systems, are also fueling market growth by offering safer, more effective treatment options. The increasing preference for outpatient care, which reduces hospitalization time and healthcare costs, is further boosting the adoption of these devices. Additionally, heightened awareness of BPH and its impact on quality of life is leading more men to seek early intervention, thus driving demand for innovative BPH devices. As these trends continue to evolve, the BPH devices market is expected to experience robust growth, supported by ongoing technological innovations and the rising demand for effective, patient-friendly treatment solutions.

Select Competitors (Total 38 Featured) -

  • Biolitec, Inc.
  • Boston Scientific Corporation
  • Lumenis Be Ltd.
  • Olympus Corporation
  • UK MEDS DIRECT Limited
  • Urologix, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Benign Prostatic Hyperplasia Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of BPH Among Aging Males Spurs Growth in BPH Devices Market
    • Increasing Preference for Outpatient Treatments Expands Addressable Market for BPH Devices
    • Growing Demand for Effective Long-Term Management Strengthens the Business Case for BPH Devices
    • Expansion of Urology Clinics and Specialized Centers Drives Adoption of BPH Devices
    • Advancements in Laser and Thermal Therapies Generate New Opportunities in BPH Devices Market
    • Push for Shorter Recovery Times Drives Demand for Minimally Invasive BPH Devices
    • Growing Use of BPH Devices in Geriatric Care Spurs Innovation in Treatment Technologies
    • Increasing Importance of Post-Treatment Monitoring Accelerates Adoption of Advanced BPH Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for TURP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Laser Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Urology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Benign Prostatic Hyperplasia Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION